| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 5,089,000 | 5,509,000 | 6,558,000 | 6,739,000 | | Cost of Revenue | 2,772,000 | 3,101,000 | 3,432,000 | 3,510,000 | | | Gross Profit | 2,317,000 | 2,408,000 | 3,126,000 | 3,229,000 | | | Operating Expenses | | Research Development | 323,000 | 346,000 | 344,000 | 363,000 | | Selling General and Administrative | 1,191,000 | 1,307,000 | 1,269,000 | 1,394,000 | | Non Recurring |
-
|
-
|
-
| 23,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 803,000 | 755,000 | 1,513,000 | 1,449,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 11,000 | 29,000 | 28,000 | 18,000 | | Earnings Before Interest And Taxes | 814,000 | 784,000 | 1,541,000 | 1,467,000 | | Interest Expense | 55,000 | 57,000 | 52,000 | 51,000 | | Income Before Tax | 759,000 | 727,000 | 1,489,000 | 1,416,000 | | Income Tax Expense | 229,000 | 186,000 | 479,000 | 453,000 | | Minority Interest |
-
| (5,000) | (19,000) | (18,000) | | | | Net Income From Continuing Ops | 530,000 | 536,000 | 991,000 | 945,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 530,000 | 536,000 | 991,000 | 945,000 | | Preferred Stock And Other Adjustments | (12,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $518,000 | $536,000 | $991,000 | $945,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
